Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Law channel feed
Judge keeps Amgen's $10.7B tax liability suit alive
7 months ago
Pharma
Federal judge dismisses longstanding suit over Bristol Myers' $74B Celgene buyout
7 months ago
Pharma
J&J pulls the plug on 340B rebate model changes opposed by government
7 months ago
Pharma
FDA+
US government renews threats over J&J's proposed 340B rebate model
8 months ago
Pharma
FDA+
Cassava and its former execs settle SEC charges for ‘misleading’ Alzheimer’s drug data
8 months ago
Pharma
Baltimore sues Biogen, saying the company colluded with PBMs to minimize generic competition
8 months ago
Pharma
Federal judge rules against Regeneron's attempt to halt Amgen from launching Eylea biosimilar
8 months ago
Pharma
House passes reauthorization of rare pediatric voucher program
8 months ago
FDA+
A small startup is challenging Epic's control over patient health records
8 months ago
Health Tech
J&J subsidiary files for third bankruptcy to settle talc claims
8 months ago
Pharma
Sen. Cassidy questions Lilly and Amgen on 340B restrictions on contract pharmacies
8 months ago
Pharma
The drug lobby's lawsuit against the IRA finds a sign of life after appeals court ruling
8 months ago
Pharma
J&J will defend its proposed 340B changes as US threatens penalties
8 months ago
FDA+
FTC to sue major PBMs over insulin rebates, claiming they inflated patient cost
8 months ago
Pharma
Cigna sues FTC, calling for withdrawal of 'biased, erroneous' PBM report
8 months ago
Pharma
Health Tech
SEC probe of Illumina’s Grail deal targets sales forecasts, sources say
8 months ago
Deals
After a huge IPO and acquisition, Zymergen caps off bankruptcy with $30M SEC penalty
8 months ago
CVS says it won't correct congressional testimony
8 months ago
Congress spars over whether the Biosecure Act is an overdue crackdown or a rushed witch hunt
8 months ago
China
FDA+
House passes Biosecure Act, sending Chinese biotech ban to Senate
8 months ago
China
Manufacturing
Federal judge rejects pharma industry’s request to halt Maryland’s 340B law
8 months ago
Pharma
J&J increases talc settlement by $1.1B after negotiating with plaintiffs, lawyers say
8 months ago
Pharma
Ocaliva will continue to be available in the EU following European court's decision
8 months ago
Pharma
Court orders J&J to pay $1B following buyout of surgical robotics company
8 months ago
Pharma
First page
Previous page
5
6
7
8
9
10
11
Next page
Last page